Driven by favorable policies related to innovative drugs, unmet clinical needs, and increased pharmaceutical R&D expenditures, it is expected that the growth rate of China's pharmaceutical market will exceed the industry average in the future, presenting a vibrant pharmaceutical market. From the domestic market perspective, with the intensification of population aging and the continuous improvement of urbanization levels, it is anticipated that the rigid demand for drugs among the population will continue to expand, and the overall pharmaceutical industry in China will show an improving trend. In terms of the composition of the pharmaceutical industry's segmented markets, the chemical drug market accounts for nearly half, followed by the traditional Chinese medicine market, and then the biopharmaceutical market.
For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released an independent research report titled 'Comprehensive Research Report on China's Pharmaceutical Market'.
The attachment is a selected version of the report. If you wish to obtain the full report or have further research needs on China's pharmaceutical market, please contact us:
Mr. Mao from Frost & Sullivan
Tel: (+86) 159-2139-6033
E-mail: fred.mao@frostchina.com
